Cellworks Group Inc., a leader in personalized therapy decision support and precision drug development, has announced promising results from a study using its computational biosimulation to predict immunotherapy (IO) responses…
SamanTree Medical, a pioneer in surgical imaging technology, has announced that its Histolog® Scanner has received FDA 510(k) clearance. This groundbreaking Swiss device offers real-time, high-resolution imaging of fresh tissue…
Massive Bio, an AI-powered clinical trial matching platform, and Foundation Medicine have announced a strategic partnership to expand patient access to advanced clinical trials. The collaboration combines Massive Bio’s patient-matching…
Medidata, a Dassault Systèmes brand and leader in clinical trial solutions for the life sciences industry, has announced a four-year extension of its partnership with the European Organisation for Research…
HDS has launched Script Scan, a new addition to its Spotlight platform. This is the company’s first product specifically designed for pharmacies. Script Scan addresses the current challenges faced by…
Catalyst OrthoScience Inc., a private medical technology company specializing in shoulder arthroplasty—the fastest growing segment in the orthopedics market—has surpassed 10,000 total shoulder arthroplasty (TSA) procedures. The milestone coincides with…
Doctors are increasingly using contrast-enhanced ultrasound (CEUS) for imaging kidney masses in patients with polycystic kidney disease, often bypassing CT scans altogether due to CEUS’s effectiveness. “They go right to…
Bristol Myers Squibb (NYSE: BMY) has announced new long-term follow-up data from the EXPLORER-LTE cohort of the MAVA-Long-Term Extension (LTE) study. This data evaluates the efficacy and safety of CAMZYOS®…
Elixir Medical, a developer of innovative cardiovascular technologies, announced that the INFINITY-SWEDEHEART Randomized Controlled Trial (RCT) has met its primary endpoint. The trial compared the novel DynamX® Coronary Bioadaptor System…
Collaborative Bridges, a network of West Side Chicago safety net hospitals and mental health agencies, has selected HealthEC’s data and analytics solution to enhance care coordination for behavioral health patients.…
Jupiter Endovascular, Inc., a medical tech innovator specializing in advanced endovascular procedures through Endoportal Control™, has received FDA approval for its Investigational Device Exemption application. This approval clears the way…
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible) announced that its AI-powered diagnostic tool, eyonis™ LCS, met the primary and all secondary endpoints in the REALITY study, the first of two…